Supraja et al., 2022 - Google Patents
Label-free, ultrasensitive and rapid detection of FDA-approved TBI specific UCHL1 biomarker in plasma using MWCNT-PPY nanocomposite as bio-electrical …Supraja et al., 2022
- Document ID
- 2763773733172759823
- Author
- Supraja P
- Tripathy S
- Vanjari S
- Singh S
- Publication year
- Publication venue
- Biosensors and Bioelectronics
External Links
Snippet
Abstract Traumatic Brain Injury (TBI), a major cause of mortality and neurological disability affecting people of all ages worldwide, remains a diagnostic and therapeutic challenge to date. Rapid, ultra-sensitive, selective, and wide-range detection of TBI biomarkers in easily …
- 239000002114 nanocomposite 0 title abstract description 52
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/543—Immunoassay; Biospecific binding assay with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means
- G01N27/02—Investigating or analysing materials by the use of electric, electro-chemical, or magnetic means by investigating the impedance of the material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using infra-red, visible or ultra-violet light
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Choudhary et al. | CD 59 targeted ultrasensitive electrochemical immunosensor for fast and noninvasive diagnosis of oral cancer | |
| Carneiro et al. | Alzheimer’s disease: Development of a sensitive label-free electrochemical immunosensor for detection of amyloid beta peptide | |
| Khan et al. | Based analytical biosensor chip designed from graphene-nanoplatelet-amphiphilic-diblock-co-polymer composite for cortisol detection in human saliva | |
| Carneiro et al. | Biosensors on the road to early diagnostic and surveillance of Alzheimer's disease | |
| Xu et al. | Detection of glial fibrillary acidic protein in patient plasma using on-chip graphene field-effect biosensors, in comparison with ELISA and single-molecule array | |
| Supraja et al. | Label-free, ultrasensitive and rapid detection of FDA-approved TBI specific UCHL1 biomarker in plasma using MWCNT-PPY nanocomposite as bio-electrical transducer: A step closer to point-of-care diagnosis of TBI | |
| Xing et al. | A sensitive and selective electrochemical biosensor for the determination of beta-amyloid oligomer by inhibiting the peptide-triggered in situ assembly of silver nanoparticles | |
| KR101774891B1 (en) | Label-free and direct detection of C-reactive protein using reduced graphene oxide-nanoparticle hybrid impedimetric sensor | |
| Phan et al. | Nanomaterial-based Optical and Electrochemical Biosensors for Amyloid beta and Tau: Potential for early diagnosis of Alzheimer’s Disease | |
| Pereira et al. | based platform with an in situ molecularly imprinted polymer for β-amyloid | |
| Supraja et al. | Towards point-of-care diagnosis of Alzheimer’s disease: Multi-analyte based portable chemiresistive platform for simultaneous detection of β-amyloid (1–40) and (1–42) in plasma | |
| Sharma et al. | Electrochemical immunosensors developed for amyloid-beta and tau proteins, leading biomarkers of Alzheimer’s disease | |
| Tao et al. | Thionine-functionalized three-dimensional carbon nanomaterial-based aptasensor for analysis of Aβ oligomers in serum | |
| Zhao et al. | Magnetic gold nanocomposite and aptamer assisted triple recognition electrochemical immunoassay for determination of brain natriuretic peptide | |
| Zakaria et al. | An impedimetric micro-immunosensing assay to detect Alzheimer's disease biomarker: Aβ40 | |
| Zheng et al. | Bioorthogonal reactions amplify magnetic nanoparticles binding and assembly for ultrasensitive magnetic resonance sensing | |
| Pankratova et al. | Electrochemical sensing of blood proteins for mild traumatic brain injury (mTBI) diagnostics and prognostics: towards a point-of-care application | |
| Chauhan et al. | Recent advances in nanosensors development for biomarker alpha-synuclein protein detection | |
| Borumand et al. | Recent trends and innovations in biosensors development for biomarkers towards monitoring traumatic brain injury | |
| Wang et al. | Multilayer heterogeneous membrane biosensor based on multiphysical field coupling for human serum albumin detection | |
| Dhahi et al. | Application of Nanobiosensor engineering in the diagnosis of neurodegenerative disorders | |
| JP2022126690A (en) | Development and parameter assessment for vertically aligned platinum wire aptasensor arrays for impedimetric detection of cardiac biomarkers | |
| Guerrero et al. | Advances for the development of in vitro immunosensors for multiple sclerosis diagnosis | |
| Djebbi et al. | NZVI© Au magnetic nanocomposite‐based electrochemical magnetoimmunosensing for ultrasensitive detection of troponin‐T cardiac biomarker | |
| Pidal et al. | Micromotor-based electrochemical immunoassays for reliable determination of amyloid-β (1–42) in Alzheimer's diagnosed clinical samples. |